2026. Formulation Strategies and In Vitro Characterization of Talquetamab-Loaded Nanocarriers for Targeted Immunotherapy in Multiple Myeloma. International Journal of Research Development and Technology. 4, 1 (Mar. 2026), 41–61. DOI:https://doi.org/10.62218/ijrdt.v4i1.166.